Advertisment

Eli Lilly and company

first case of coronavirus variant XE, new covid treatment guidelines ,Omicron Cases Spike In India, Rochelle Walensky On Omicron, omicron FAQ, omicron reinfection rate high, india omicron cases ,Omicron India Tally ,Omicron in India ,COVID-19 Booster Shots In India ,Omicron positive cases in india ,COVID Omicron variant ,Cases Of Omicron In India, First Omicron case in US, WHO On Omicron, Omicron variant ,COVID Positive South Africans In Bengaluru ,Two South Africans Test Positive ,omicron, what is horse antisera ,new coronavirus strain, South African COVID Variant ,first known case of COVID-19 ,New Coronavirus Variant, what is mu mutation, COVID-19 third wave in India, covid effect on brain, what is gamma variant, Long COVID Symptoms ,Corona Third Wave Early Stage, XBB variant, Long COVID-19, brain fog, Long COVID Origin

Eli Lilly Gets Emergency Use Permit For Antibody Drugs To Treat COVID-19 Patients In India

Bamlanivimab and etesevimab combined can be given to adults and paediatric patients (12 years and older of at least 40 kg weight) in a restricted manner via injections. Mild and moderate cases of COVID-19 can be treated with the drug.

By STP Reporter

Jun 01, 2021 11:16 IST logo

2 Min read

Advertisment